EW logo

EW

Edwards Lifesciences Corporation

$82.65
+$1.29(+1.59%)
56
Overall
80
Value
45
Tech
44
Quality
Market Cap
$44.77B
Volume
3.78M
52W Range
$65.94 - $87.89
Target Price
$96.75

Company Overview

Mkt Cap$44.77BPrice$82.65
Volume3.78MChange+1.59%
P/E Ratio10.7Open$81.44
Revenue$5.4BPrev Close$81.36
Net Income$4.2B52W Range$65.94 - $87.89
Div YieldN/ATarget$96.75
Overall56Value80
Quality44Technical45

No chart data available

About Edwards Lifesciences Corporation

Edwards Lifesciences Corporation provides products and technologies to treat advanced cardiovascular diseases in the United States, Europe, Japan, and internationally. The company offers transcatheter heart valve replacement products for minimally invasive replacement of aortic heart valves under the Edwards SAPIEN family of valves system; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases under the PASCAL PRECISION and Cardioband brands. It also provides surgical structural heart solutions, such as aortic surgical valve under the INSPIRIS brand name; INSPIRIS RESILIA aortic valve, which offers RESILIA tissue and VFit technology; KONECT RESILIA, a pre-assembled tissue valve conduit for complex combined procedures; and MITRIS RESILIA valve. The company distributes its products through a direct sales force and independent distributors. Edwards Lifesciences Corporation was founded in 1958 and is headquartered in Irvine, California.

Sector: Healthcare
Industry: Medical Devices
ABCD
1SymbolPriceChangeVol
2EW$82.65+1.6%3.78M
3
4
5
6

Get Edwards Lifesciences Corporation Data in Excel

Stream real-time data directly to your spreadsheets

BUY NOW
Stock data provided by MarketXLS.